[MYGN] QoQ Quarter Result on 30-Sep-2020 [#Q3]

Stock
[MYGN] Myriad Genetics, Inc.
Announcement Date
09-Nov-2020
Financial Year
2020
Quarter
30-Sep-2020 [#Q3]
Profit Trend
QoQ- 72.56%
YoY- 26.21%
Quarter Report
MYGN's Result
MYGN's Financial Summary
View:
Show?
Quarter Result
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Revenue 189,400 173,100 154,600 145,200 93,200 164,000 195,100 -1.95%
PBT -3,800 -49,600 -55,700 -43,700 -58,500 -131,100 -11,400 -51.95%
Tax 900 -10,100 -11,500 -28,500 -3,000 -15,900 -3,100 -
NP -4,700 -39,500 -44,200 -15,200 -55,400 -115,200 -8,300 -31.57%
Tax Rate - - - - - - - -
Total Cost 194,100 212,600 198,800 160,400 148,600 279,200 203,400 -3.07%
Ratio Analysis
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
NP Margin -2.48 -22.82 -28.59 -10.47 -59.44 -70.24 -4.25 -30.19%
Per Share
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
EPS -0.06 -0.52 -0.59 -0.20 -0.74 -1.55 -0.11 -33.26%
EPS Diluted -0.06 -0.52 -0.59 -0.20 -0.74 -1.55 -0.11 -33.26%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.